Understanding the science behind the six-treatment protocol, what research tells us, and what we’ve learned after more than 12,000 ketamine treatments at Illumma.
Key Takeaways
- Six treatments are based on published research—not marketing.
- Ketamine works by temporarily increasing neuroplasticity.
- Most patients do not experience their full benefit after one infusion.
- At Illumma, only about 10% notice improvement after the first treatment.
- About 60% begin noticing changes between treatments three and four.
- Approximately 80% experience meaningful improvement by completing the induction series.
- Healing often continues for weeks after treatment ends.
If you’ve researched ketamine therapy, you’ve probably noticed something almost every clinic has in common: they recommend an initial series of six treatments. Why six? Is it based on science? Marketing? Insurance? Or is it simply what everyone else does? That recommendation isn’t arbitrary, and it isn’t about selling more treatments. It’s based on decades of research into how ketamine affects the brain and reinforced by what we’ve observed after caring for more than 1,200 patients and providing over 12,000 ketamine infusions. Understanding why six treatments are recommended can help you set realistic expectations and give yourself the best opportunity for lasting healing.
Why Do I Need Six Treatments?
One of the most common questions we hear from prospective patients is: “If ketamine works so quickly, why do I need six treatments? Can’t I just try one?” It’s a completely reasonable question. Many people begin exploring ketamine therapy after years of struggling with depression, anxiety, PTSD, chronic stress, or chronic pain. When they hear that ketamine can begin working within hours or days, it’s natural to wonder why a series of treatments is recommended instead of a single infusion. The answer is that ketamine isn’t designed to simply provide a temporary mood boost. Its greatest strength lies in its ability to help the brain become more adaptable, a process known as neuroplasticity. Like most meaningful changes in the body, that process works best with repetition. At Illumma Ketamine Clinic, we’ve provided more than 12,000 ketamine treatments to over 1,200 patients. While every person responds differently, we’ve consistently seen that completing the recommended initial series gives most patients the best opportunity for lasting improvement.
One Treatment Opens the Door. Six Treatments Help You Walk Through It.
While some people notice rapid relief after a single treatment, ketamine’s greatest potential lies in helping the brain create lasting change over time. Let’s explore why.
Where Did the Six-Treatment Protocol Come From?
One misconception is that clinics simply chose the number six because it sounded reasonable. In reality, the six-treatment protocol developed from early clinical research on ketamine for treatment-resistant depression. Researchers found that while many patients experienced rapid improvement after an infusion, repeated treatments produced more durable and consistent results than a single dose. Today, repeated dosing has become the standard approach across many ketamine programs. Even Spravato® (esketamine), the FDA-approved nasal spray for treatment-resistant depression, follows a structured schedule with multiple treatments over several weeks rather than a one-time dose. The goal isn’t simply to help someone feel better for a few days. The goal is to create the conditions for the brain to build healthier, more resilient patterns that can last long after treatment ends. At Illumma, we typically schedule the induction series as one treatment per week for six weeks. This cadence gives patients time to integrate each experience while maintaining the momentum of repeated treatments. As always, schedules may be adjusted based on individual needs and clinical response. While you’ll often hear us refer to a “six-treatment series,” it’s important to know that six is a starting point—not a finish line. Every treatment plan at Illumma is personalized, and some patients benefit from a slightly longer induction series before transitioning to maintenance.
Ketamine Doesn’t Just Change Mood, It Changes How the Brain Learns
One of the most exciting discoveries in neuroscience is that the adult brain remains capable of change throughout life. This ability is called neuroplasticity.
Ketamine creates a temporary window of increased neuroplasticity, giving the brain an opportunity to build healthier neural pathways.
When someone experiences depression, PTSD, anxiety, or chronic stress, the brain often becomes stuck in well-established patterns. Thoughts, emotions, and behaviors begin reinforcing one another until they feel automatic. Ketamine appears to temporarily increase the brain’s ability to form and strengthen new neural connections. Research suggests it influences glutamate signaling and stimulates the release of brain-derived neurotrophic factor (BDNF), a protein involved in learning, memory, and neural growth. While the science continues to evolve, the practical takeaway is simple: Ketamine creates a window during which the brain may be more capable of change. That doesn’t mean the work is finished after one treatment. It means the brain has been given an opportunity to begin building something new.
Why This Matters for the Six-Treatment Protocol
This is one of the primary reasons most ketamine clinics recommend an initial series of six treatments instead of a single infusion. Rather than viewing each infusion as an isolated event, it’s more helpful to think of each treatment as building on the one before it. Every session provides another opportunity for the brain to strengthen healthier neural pathways while neuroplasticity is temporarily increased. Although every person’s response is different, repeated treatments appear to create a stronger foundation for lasting change than a single treatment alone. That’s why decades of research, current clinical practice, and our own experience caring for more than 1,200 patients all support completing the initial treatment series whenever appropriate.¹⁻⁵
Think of It Like Creating a New Trail
Neuroplasticity can feel like an abstract scientific concept, but it becomes much easier to understand when we compare it to something familiar. Imagine walking through a field every day for years. Eventually, a deep, well-worn path develops. Creating a brand-new trail isn’t accomplished by walking it once. The more often you choose the new route, the stronger and easier it becomes, while the old path gradually becomes less dominant. Depression, anxiety, trauma, and chronic stress can work similarly. Our brains naturally repeat familiar patterns—even when those patterns no longer serve us. Ketamine appears to make it easier to begin creating healthier pathways, but those pathways are strengthened through repeated opportunities, supportive therapy, intentional habits, and time. That’s why most treatment plans include multiple sessions rather than expecting a single infusion to permanently change years of established neural patterns.
Just as a trail becomes easier to follow with repeated use, healthier neural pathways become stronger through repetition, integration, and time.
Why One Treatment Rarely Tells the Full Story
Every patient’s experience is unique. Some people notice dramatic improvement after their first infusion. Others don’t. Neither experience predicts the final outcome. In fact, it’s common for progress to unfold gradually. One person might notice they sleep through the night for the first time in months. Someone else realizes their anxiety isn’t controlling every decision. Another patient may not recognize significant change until a spouse, friend, or coworker comments that they seem lighter, calmer, or more engaged. Improvement often builds over the course of treatment rather than arriving all at once. This is one reason we encourage patients to avoid judging the effectiveness of ketamine after a single session.
Healing Isn’t Always Linear
Another important reality is that healing rarely follows a straight line. Some patients feel significantly better after an early treatment. Others experience emotional processing before noticeable symptom relief. Some have excellent sessions followed by more challenging ones. This doesn’t necessarily mean treatment isn’t working. Ketamine can bring increased awareness of emotions, memories, or thought patterns that have been buried beneath years of stress or survival mode. While this process can feel uncomfortable, it may also create opportunities for meaningful healing—particularly when combined with preparation, integration, and ongoing therapeutic support. At Illumma, we remind patients that the goal isn’t simply to have six “good” treatment days. The goal is to support lasting change that continues long after the treatment series is complete.
Why Some People Stop Too Soon
One of the biggest barriers to success is stopping treatment before giving the process enough time. Common reasons include:
- “I felt better after two treatments, so I don’t think I need more.”
- “I didn’t notice much after my first treatment.”
- “Life got busy.”
- “I’m not sure it’s worth continuing.”
These reactions are understandable. But stopping after one or two treatments is a bit like attending two physical therapy appointments after a major injury and expecting complete recovery. You may have started the healing process, but your body and your brain often need additional opportunities to strengthen those changes. Completing the recommended series gives both you and your care team a much clearer understanding of how your brain responds to treatment and what your long-term maintenance plan should look like.
What We’ve Learned After More Than 12,000 Ketamine Treatments
Clinical research provides the foundation for ketamine therapy, but one of the greatest advantages of choosing an experienced clinic is benefiting from thousands of real-world patient outcomes. Since opening our doors in 2018, Illumma has provided more than 12,000 ketamine infusions over 7.5 years and cared for more than 1,200 patients. Every person’s healing journey is unique, and no clinic can guarantee specific results. However, tracking patient progress over time has allowed us to identify consistent patterns that help us set realistic expectations. While patient testimonials provide valuable insight, we’ve also chosen to systematically track patient outcomes using standardized assessments. Every patient completes standardized mental health assessments before beginning treatment and before every infusion, allowing us to measure changes over time rather than relying on memory alone.
Healing is often gradual. These trends reflect what we’ve observed after more than 12,000 ketamine treatments at Illumma.
How We Track Outcomes at Illumma
One of our core beliefs is that great care should be measurable. Unlike many clinics that rely primarily on patient testimonials or anecdotal feedback, we’ve systematically tracked patient outcomes since opening our doors in 2018. Every patient completes standardized mental health assessments before beginning treatment and again before each infusion. This allows us to objectively monitor changes in symptoms over time rather than relying solely on memory or subjective impressions. We use three validated screening tools that are widely used in both clinical practice and research:
- PHQ-9 to measure symptoms of depression
- GAD-7 to measure symptoms of anxiety
- PCL-5 to measure symptoms of post-traumatic stress disorder (PTSD)
While these assessments provide valuable objective data, they don’t tell the whole story. That’s why we also ask patients about the meaningful changes they’re experiencing in everyday life—sleeping better, reconnecting with loved ones, finding joy in activities again, exercising, practicing better self-care, and feeling more hopeful about the future. By combining standardized symptom tracking with real-world quality-of-life measures, we’re able to better understand each patient’s progress and continually evaluate the effectiveness of our treatment approach.
Healing Is Usually Gradual, Not Instant
One of the biggest misconceptions about ketamine therapy is that you’ll know whether it works after your first treatment. While ketamine can produce rapid changes for some people, that isn’t the most common experience. Based on our clinical outcome data:
- About 10% of patients notice a meaningful improvement after their first infusion.
- Approximately 60% begin feeling a noticeable shift between their third and fourth treatments.
- By the end of the recommended six-treatment induction series, about 80% of patients achieve at least a 20% reduction in symptoms.
- Nearly one in three patients (30%) experience a 70% or greater reduction in symptoms by the completion of their induction series.
These observations align with published research demonstrating that repeated ketamine treatments generally produce more durable and meaningful improvements than a single infusion.¹² This is one of the primary reasons we encourage patients not to judge their progress after just one or two treatments. Healing often builds gradually as the brain repeatedly enters a state that supports learning, adaptation, and neuroplasticity.³⁻⁵
Healing isn’t always dramatic. Often, the first signs of progress show up in everyday life.
Healing Continues After the Sixth Treatment
Another important observation is that the sixth infusion isn’t the finish line. Approximately four weeks after completing the induction series, every patient participates in a follow-up assessment. One of our goals isn’t simply to maintain the progress achieved during treatment—it’s to see continued improvement. Many patients continue feeling better during the weeks following their induction series as they integrate what they’ve learned, build healthier routines, strengthen relationships, and continue taking advantage of the increased neuroplasticity that ketamine may create. This is one reason we place such a strong emphasis on preparation, integration, lifestyle habits, and ongoing support. Ketamine opens the door, but lasting healing comes from walking through it.
What Happens After Six Treatments?
Completing the initial series isn’t the end of treatment. It’s the beginning of maintenance. Just as someone with high blood pressure or diabetes may require ongoing care, many people benefit from occasional ketamine booster treatments to help maintain progress. The good news is that boosters are highly individualized. Some patients return every month. Others come every few months. Some only schedule a booster during periods of increased stress or after major life events. The goal isn’t to receive ketamine forever. The goal is to provide support only when it’s helpful, while continuing to build resilience through healthy habits, therapy, movement, relationships, sleep, nutrition, and purposeful living. A booster isn’t a sign of failure. It’s simply one tool that can help maintain the progress you’ve worked so hard to achieve. At Illumma, we don’t schedule boosters on a fixed calendar. Instead, we base maintenance recommendations on symptom scores, your lived experience, and how long the benefits of treatment continue between sessions.
Frequently Asked Questions
Can I stop after four treatments?
Every person responds differently, so there isn’t a single number that’s right for everyone. At Illumma, we generally recommend an initial induction series of 6–10 treatments, but we don’t decide that from the start. Around your fourth or fifth treatment, we’ll review your symptom scores, discuss your experience, and evaluate whether the benefits are becoming stronger and lasting longer between sessions. If so, six treatments may be the right stopping point. If you’re still building momentum, we may recommend extending your induction series. Our goal isn’t to reach a certain number of treatments—it’s to create the best long-term outcome for you.
What if I don’t notice anything after my first treatment?
That’s actually very common. Only about 10% of our patients report meaningful improvement after their first infusion. Most people begin noticing changes around treatments three or four, and many continue improving throughout the six-week induction series and even during the weeks afterward. A single treatment rarely tells the whole story.
What if I feel much better after one or two treatments?
That’s wonderful—and it happens. However, early improvement doesn’t necessarily mean your brain has fully consolidated those changes. Completing the recommended induction series gives those healthier neural pathways additional opportunities to strengthen, which may lead to more durable, long-lasting results.
What if I miss a treatment?
Life happens. Missing one treatment doesn’t mean you have to start over. At Illumma, our standard induction series is one treatment per week for six weeks. If you need to reschedule, we’ll work with you to adjust your plan while maintaining as much momentum as possible.
Can I spread my treatments farther apart?
During the induction series, we generally recommend weekly treatments because repeated sessions help reinforce the brain’s increased neuroplasticity. After completing your induction series, booster treatments are scheduled based on your individual needs—not on a fixed calendar.
How do you know whether ketamine is working?
Improvement isn’t always dramatic. Often, the earliest changes are subtle. You may notice you’re sleeping better, feeling less reactive, enjoying activities again, reconnecting with loved ones, exercising more, or recovering from stressful situations more quickly. That’s why we measure both standardized symptom scores and the everyday quality-of-life changes that matter most to you.
Will I need booster treatments?
Maybe, but not necessarily. Some patients don’t need another treatment for many months. Others benefit from occasional boosters during periods of increased stress or symptom recurrence. At Illumma, we don’t schedule boosters automatically. We base maintenance recommendations on your symptom scores, your experience, and how long the benefits continue between treatments.
Does ketamine work better with therapy?
Research and our clinical experience both suggest that ketamine is often most effective when combined with psychotherapy, healthy lifestyle habits, preparation, and integration. Ketamine creates an opportunity for change. Therapy and intentional action help transform that opportunity into lasting healing.
Does ketamine cure depression, PTSD, or anxiety?
No. Ketamine isn’t considered a cure. Instead, it may reduce symptoms, increase neuroplasticity, and help create the conditions for meaningful, lasting change. Many patients experience their best outcomes when ketamine is part of a comprehensive treatment plan.
How will I know if ketamine isn’t right for me?
Not everyone responds to ketamine in the same way. Throughout treatment, we’ll monitor your symptom scores, discuss your experience, and evaluate your progress together. If ketamine isn’t producing meaningful benefit, we’ll have an honest conversation about your options and help guide you toward the care that’s most appropriate for your situation.
Why does Illumma recommend one treatment per week instead of multiple treatments each week?
There isn’t a single “correct” ketamine protocol, and treatment schedules vary between clinics. At Illumma, our standard induction series is one treatment per week for six weeks. We believe this schedule gives patients time to integrate each experience, apply what they’re learning, and build lasting change while still maintaining the momentum of repeated treatments. As with every aspect of care, your treatment plan can be adjusted based on your individual response and clinical needs.
The Bottom Line
Ketamine therapy isn’t about chasing a temporary feeling of relief. It’s about creating an opportunity for your brain to become more flexible, more resilient, and more capable of change. While some people experience dramatic improvement after their first treatment, lasting transformation often develops over time. That’s why decades of research, modern clinical practice, and our experience providing more than 12,000 ketamine treatments all support an initial series rather than judging success after a single session. If you’re considering ketamine therapy, remember this: One treatment may open the door. Completing the series gives your brain the best opportunity to walk through it.
Wondering Whether Ketamine Therapy Is Right for You?
Choosing a ketamine clinic is an important decision. During your consultation, we’ll discuss: ✓ your symptoms ✓ your goals ✓ your medical history ✓ whether ketamine is appropriate ✓ whether IV ketamine, KAT, Spravato®, or another approach makes the most sense. Whether you decide to pursue treatment with us or not, we want you to leave your consultation with a better understanding of your options. Schedule your consultation today.
Not sure what progress is supposed to feel like? Read: How Do I Know If Ketamine Is Working?
References
- Murrough JW, et al. Antidepressant Efficacy of Repeated Ketamine Infusions for Treatment-Resistant Major Depression. American Journal of Psychiatry. 2013. https://pubmed.ncbi.nlm.nih.gov/23982301/
- Phillips JL, et al. Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression. American Journal of Psychiatry. 2019. https://pubmed.ncbi.nlm.nih.gov/30922101/
- Duman RS, Aghajanian GK. Synaptic Dysfunction in Depression and the Therapeutic Actions of Ketamine. Science. 2012. https://pubmed.ncbi.nlm.nih.gov/22798606/
- Krystal JH, Abdallah CG, Sanacora G, et al. Ketamine: A Paradigm Shift for Depression Research and Treatment. Neuron. 2019. https://pubmed.ncbi.nlm.nih.gov/30784519/
- Feder A, et al. Efficacy of Repeated Ketamine Administration for Chronic PTSD. American Journal of Psychiatry. 2021. https://pubmed.ncbi.nlm.nih.gov/33397139/
Illumma outcome data is derived from internal clinical tracking across more than 12,000 ketamine infusions over 7.5 years. Individual results vary, and no specific outcome can be guaranteed
Reviewed by Alli Waddell, Founder & CEO of Illumma Ketamine Clinic
Alli has spent more than eight years helping develop ketamine treatment programs and has supported over 12,000 ketamine treatments alongside the Illumma clinical team. She is passionate about making evidence-based mental health care accessible through compassionate education.
Medically reviewed by Dr. Ken Adolph, MD, Medical Director of Illumma Ketamine Clinic
Published: July 2026
Last Updated: September 5, 2026